摘要 |
<P>PROBLEM TO BE SOLVED: To provide a new improving medicine for metabolic syndrome. <P>SOLUTION: The invention relates to the compound represented by general formula (I) or its salt having 11β-HSD1 inhibiting activity and to the method for producing the compound, [in the formula, R is -CH<SB>2</SB>CH<SB>2</SB>OH, -CH(CO<SB>2</SB>H)CH<SB>2</SB>CH<SB>2</SB>CO<SB>2</SB>H, -H, or -CH<SB>2</SB>COOH]. <P>COPYRIGHT: (C)2008,JPO&INPIT |